CRBU
Caribou Biosciences Inc
1.20$
-2.5%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 76.7% | 78.4% | 74.9% | 72.6% | 69.0% | 70.0% | 79.4% | 87.1% | 79.8% | 80.8% | 82.1% | 81.7% | |
| 22.7% | 11.8% | 12.1% | 10.2% | 9.3% | 5.2% | 10.7% | 11.4% | 5.7% | 6.9% | 8.1% | 18.3% | |
| 74.0% | 76.1% | 72.3% | 70.2% | 66.3% | 66.9% | 76.2% | 83.3% | 75.5% | 77.6% | 78.9% | 78.7% | |
| 1.1% | 0.9% | 0.9% | 0.8% | 0.8% | 1.0% | 1.0% | 1.3% | 1.5% | 1.7% | 1.6% | 1.4% | |
| 1.2% | – | – | – | 0.2% | – | – | – | – | – | – | – | |
| 13.0% | 14.8% | 15.6% | 16.8% | 18.3% | 19.3% | 20.6% | 24.8% | 27.3% | 32.0% | 31.5% | 31.3% | |
| 5.4% | 6.5% | 7.1% | 8.3% | 9.3% | 9.8% | 10.4% | 13.1% | 14.4% | 14.1% | 13.2% | 12.6% | |
| 0.2% | 0.3% | 0.7% | 0.8% | 0.3% | 0.5% | 0.7% | 1.0% | 1.4% | 0.7% | 0.9% | 1.0% | |
| 0.5% | 0.7% | 1.5% | 0.9% | 0.8% | 0.8% | 1.4% | 1.5% | 2.0% | 3.2% | 2.4% | 2.2% | |
| 87.0% | 85.2% | 84.4% | 83.2% | 81.7% | 80.7% | 79.4% | 75.2% | 72.7% | 68.0% | 68.5% | 68.7% | |
| -57.9% | -69.2% | -83.7% | -101.4% | -119.9% | -143.1% | -178.5% | -245.6% | -292.3% | -332.1% | -417.2% | -452.4% | |
| 18.3% | 20.5% | 22.0% | 24.2% | 26.3% | 28.8% | 33.9% | 42.1% | 47.8% | 52.6% | 64.3% | 70.7% |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.